Thank you for once again establishing that current general large language model AI is little more than a very articulate dot connecting machine that fails to understand what it is printing.
In the same response where it answers ":yes" to your question it leads with:
"RWD, which is data collected from diverse sources outside of traditional clinical trials, can be used to form external control arms in clinical trials. "
AI just does not understand the contradiction, because it understands nothing.
Here is what Dr. Liau had to say about data from other controlled trials, from 2022 at WCM Neurosurgey Grand Rounds - "45:16 treatments uh non-invasively um and then you know 45:21 these previously large randomized controlled trials have been done in glioblastoma it would be good if these 45:27 uh trials uh release their data um so that it could be mined for 45:32 uh external controlled propensity matching and uh and also i think um 45:39 the you know more of a movement towards the use of external control arms for registration on our trials or even going"
When she has spoken about external data she has been talking about data from controlled studies, not just real world data
don't know if link will work but can search for Liau and title of her talk was 'Targeting Immunotherapy - induced Resistance in Glioblastoma'
Market Data 
Markets 
AI
